SMAD7 and Hepatic fibrosis: In the miR-29a transgenic mice, Smad7 maintained an abundance that was more than twice as great (miR-29a-sham vs. WT-sham, p < 0.001), thus providing evidence of its protection ability against liver fibrosis (Figure 3a).